Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Paint The Table -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (4764)	12/5/2001 11:06:47 AM
From: Don Pueblo	Read Replies (2) \| Respond to of 23786

I called this short squeeze on Monday. When it didn't happen, I thought I couldn't read the chart right. Then on Tuesday, I shorted right into the squeeze. Got out early in the day break even and watched the NAZ scream up while I was sitting there trying to figure out the next short entry spot. Missed the long plays (like ERTS, which I was playing...) on the short squeeze totally. DOH! It's a good thing I'm not a professional football player or I would have been looking the wrong way when John Lynch launched himself at me. Not to mention the setback to my doctoral thesis, "Generating Income from Wavy Lines By Actually Paying Attention".

To: Jorj X Mckie who wrote (4764)	12/5/2001 11:08:26 AM
From: Neenny	Read Replies (1) \| Respond to of 23786

Any thoughts/charts on ACAM or BAX?? U.S. to Stockpile Smallpox Vaccine By LAURA MECKLER .c The Associated Press WASHINGTON (Nov. 29) - The Bush administration says it will have enough smallpox vaccine on hand within a year to inoculate every American, but officials have no plans to use it absent a return of the virtually extinct but deadly virus. The Department of Health and Human Services signed a contract Wednesday to buy 155 million doses of vaccine from a British company, preparing for the possibility terrorists would try to spread the highly contagious disease. The contract with Acambis Inc. is supposed to bring the nation's stockpile to 286 million doses of the vaccine by the end of next year, promising protection for every American. But there are no plans to resume the routine vaccinations of Americans that ended in 1972, HHS Secretary Tommy Thompson said. That's because the vaccine can be administered four days after exposure to smallpox and still offer protection and because it can cause some rare but deadly side effects. Still, Thompson predicted that the contract would prompt demand for the shots by many Americans. ``That discussion is not only going to be taking place here in the department, but in Congress, at the White House and across America,'' he said. Smallpox hasn't occurred in the United States since 1949 and was declared eradicated worldwide in 1980. But the Centers for Disease Control and Prevention in Atlanta and a Moscow laboratory hold stocks of the virus, and bioterrorism experts worry that samples could fall into terrorists' hands and be used as a weapon. Experts believe such a smallpox attack is unlikely, but it could overwhelm communities were it to occur. The virus is highly contagious, and nearly a third of its victims die. ``The risk does exist and we must be prepared,'' Thompson said. ``Obtaining the vaccine represents an important insurance policy,'' added Dr. D.A. Henderson, who led the global campaign that eliminated smallpox and is now Thompson's top bioterrorism adviser. ``It's simply a prudent thing to do at this point in time.'' But the risk of a smallpox attack is not significant enough to justify the risks associated with the vaccine, he said. About three in every 1 million people vaccinated would get encephalitis, which can cause permanent brain damage or death. Another 250 among the total population vaccinated would get a smallpox-like rash that also can be fatal if not properly treated. And experts estimate that if every American were vaccinated against smallpox, about 400 people would die from the vaccine. ``It causes more complications than any vaccine we now have,'' Henderson said. Should smallpox reappear, a federal response plan calls for isolating the patient and then vaccinating those in close contact with him or her. The government already has 15.4 million doses of smallpox vaccine on hand, and officials are prepared to dilute each one to create five doses, bringing the total to 77 million. Researchers are studying whether each dose could be further diluted, to get 10 doses from each one. In either case, the diluted vaccine would be used only if the new doses had not yet been delivered, or if they ran out, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease. An additional 54 million doses already have been ordered from Acambis and are expected to be delivered next year. The new contract will bring another 155 million doses, which are expected by late fall 2002. They will cost the government $428 million, or $2.76 per dose. That's less than the $509 million that the Bush administration has asked from Congress to pay for the new vaccine. The initial budget request assumed that the government would need to buy 250 million doses, but new research has found that the existing vaccine can safely be diluted, meaning much less new vaccine is needed. To make the newest batch of vaccine, Acambis has teamed with Baxter International, which will begin brewing doses immediately at an undisclosed European factory, Acambis spokeswoman Lyndsay Wright said. Acambis' own manufacturing will begin soon at a factory in Cambridge, Mass., she said. After the vaccine is manufactured, it must be tested in clinical trials and then approved by the Food and Drug Administration. The FDA promised an expedited review but vowed not to lower its standards. AP-NY-11-29-01 0612EST Copyright 2001 The Associated Press. The information contained in the AP news report may not be published, broadcast, rewritten or otherwise distributed without the prior written authority of The Associated Press. All active hyperlinks have been inserted by AOL. AOL: AOL News: U.S. to Stockpile Smallpox Vaccine